Protein kinase Cδ as gonadotropin-releasing hormone target isoenzyme in the αT3-1 gonadotrope cell line

Neuroendocrinology

Volumn 79, Issue 4, 2004, Pages 204-220

  Maccario, Hélène ^a   Junoy, Brice ^a   Poulin, Benoit ^a   Boyer, Bénédicte ^a   Enjalbert, Alain ^a   Drouva, Sophia V ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Fac Med Nord   (France)

Author keywords

T3 1 cell line; Gonadotropes; Gonadotropin releasing hormone; Phosphorylation; Proteasome; Protein kinases

Indexed keywords

ANTIBODY; GONADORELIN; ISOENZYME; ITURELIX; NEUROPEPTIDE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; SERINE; THREONINE; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; ONCOPROTEIN; PRKCD PROTEIN, HUMAN; PRKCE PROTEIN, HUMAN; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL FRACTIONATION; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; GONADOTROPIN SECRETING CELL; HORMONAL REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REFRACTORY PERIOD; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; ISOENZYMES; MULTIENZYME COMPLEXES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 2542629710     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078102     Document Type: Article

References (64)

1. Black JD: Protein kinase C-mediated regulation of the cell cycle. Front Biosci 2000;5:D406-D423.
2. Gschwendt M: Protein kinase Cδ. Eur J Biochem 1999;259:555-564.
3. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
4. Liu WS, Heckman CA: The sevenfold way of PKC regulation. Cell Signal 1998;10:529-542.
5. Newton AC: Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors and macromolecular interactions. Chem Rev 2001;101:2353-2364.
6. Junoy B, Maccario H, Mas JL, Enjalbert A, Drouva SV: Proteasome implication in phorbol ester- and GnRH-induced selective down-regulation of PKC (α, ε, ζ) in αT3-1 and LβT2 gonadotrope cell lines. Endocrinology 2002;143:1386-1403.
7. 2+ and protein kinase C. Front Neuroendocrinol 1998;19:1-19.
8. Poulin B, Rich N, Mitev Y, Gautron JP, Kordon C, Enjalbert A, Drouva SV: Differential involvement of calcium channels and protein kinase-C activity in GnRH-induced phospholipase-C, -A2 and -D activation in a gonadotrope cell line (αT3-1). Mol Cell Endocrinol 1996;122:33-50.
9. Stojilkovic SS, Catt KJ: Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. J Neuroendocrinol 1995;7:739-757.
10. Cheng KW, Ngan ES, Kang SK, Chow BK, Leung PC: Transcriptional down-regulation of human gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: Role of protein kinase C and activating protein 1. Endocrinology 2000;141:3611-3622.
11. Drouva SV, Gorenne I, Laplante E, Rerat E, Enjalbert A, Kordon C: Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology 1990;126:536-544.
12. Drouva SV, Poulin B, Manceau V, Sobel A: Luteinizing hormone-releasing hormone-signal transduction and stathmin phosphorylation in the gonadotrope αT3-1 cell line. Endocrinology 1998;139:2235-2239.
13. Kratzmeier M, Poch A, Mukhopadhyay AK, McArdle CA: Selective translocation of nonconventional protein kinase C isoenzymes by gonadotropin-releasing hormone in the gonadotrope-derived αT3-1 cell line. Mol Cell Endocrinol 1996;118:103-111.
14. Kraus S, Naor Z, Seger R: Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res 2001;32:499-509.
15. Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ: GnRH activates ERK1/2 leading to the induction of c-fos and LHβ protein expression in LβT2 cells. Mol Endocrinol 2002;16:419-434.
16. Vasilyev VV, Pernasetti F, Rosenberg SB, Barsoum MJ, Austin DA, Webster NJ, Mellon PL: Transcriptional activation of the ovine follicle-stimulating hormone-β gene by gonadotropin-releasing hormone involves multiple signal transduction pathways. Endocrinology 2002;143:1651-1659.
17. Harris D, Reiss N, Naor Z: Differential activation of protein kinase Cδ and ε gene expression by gonadotropin-releasing hormone in αT3-1 cells. Autoregulation by protein kinase C. J Biol Chem 1997;272:13534-13540.
18. Maccario H, Junoy B, Poulin B, Enjalbert A, Drouva SV: Translocation associated with the phosphorylation state and activation of nPKCs (ε, δ, and θ), GnRH-target isoenzymes in αT3-1 and LβT2 gonadotrope cell lines. FEBS Special Meeting on Signal Transduction, Brussels 2003. Eur J Biochem 2003;270(suppl 1):abstr 732, p 178.
19. Poulin B, Rich N, Mas JL, Kordon C, Enjalbert A, Drouva SV: GnRH signalling pathways and GnRH-induced homologous desensitization in a gonadotrope cell line (αT3-1). Mol Cell Endocrinol 1998;142:99-117.
20. Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR: Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C isoforms. FEBS Lett 2000;484:217-223.
21. Kikkawa U, Matsuzaki H, Yamamoto T: Protein kinase Cδ: Activation mechanisms and functions. J Biochem (Tokyo) 2002;132:831-839.
22. Liu Y, Graham C, Li A, Fisher RJ, Shaw S: Phosphorylation of the protein kinase Cθ activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-κB induction. Biochem J 2002;361:255-265.
23. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ: Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-2045.
24. Jaken S, Parker PJ: Protein kinase C binding partners. Bioessays 2000;22:245-254.
25. Eto A, Akita Y, Saido TC, Suzuki K, Kawashima S: The role of the calpain-calpastatin system in thyrotropin-releasing hormone-induced selective down-regulation of a protein kinase C isozyme, nPKC ε, in rat pituitary GH4C1 cells. J Biol Chem 1995;270:25115-25120.
26. Kiley SC, Parker PJ, Fabbro D, Jaken S: Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells. J Biol Chem 1991;266:23761-23768.
27. Olivier AR, Parker PJ: Bombesin, platelet-derived growth factor and diacylglycerol induce selective membrane association and down-regulation of protein kinase C isotypes in Swiss 3T3 cells. J Biol Chem 1994;269:2758-2763.
28. Shih NY, Floyd-Smith G: Protein kinase Cδ mRNA is down-regulated transcriptionally and post-transcriptionally by 12-O-tetradecanoylphorbol-13- acetate. J Biol Chem 1996;271:16040-16046.
29. Young S, Parker PJ, Ullrich A, Stabel S: Downregulation of protein kinase C is due to an increased rate of degradation. Biochem J 1987;244:775-779.
30. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M, Kuroda T, Nishizuka Y: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 1989;264:4088-4092.
31. Lee HW, Smith L, Pettit GR, Vinitsky A, Smith JB: Ubiquitination of protein kinase Cα and degradation by the proteasome. J Biol Chem 1996;271:20973-20976.
32. Lee HW, Smith L, Pettit GR, Smith JB: Bryostatin 1 and phorbol ester down-modulate protein kinase Cα and -ε via the ubiquitin/proteasome pathway in human fibroblasts. Mol Pharmacol 1997;51:439-447.
33. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA: Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 1998;18:839-845.
34. Hansra G, Garcia-Paramio P, Prevostel C, Whelan RD, Bornancin F, Parker PJ: Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. Biochem J 1999;342:337-344.
35. Lee HW, Smith L, Pettit GR, Bingham Smith J: Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin. Am J Physiol 1996;271:C304-C311.
36. Srivastava J, Procyk KJ, Iturrioz X, Parker PJ: Phosphorylation is required for PMA- and cellcycle-induced degradation of protein kinase Cδ. Biochem J 2002;368:349-355.
37. Barbieri RL: Clinical applications of GnRH and its analogues. Trends Endocrinol Metab 1992;3:30-34.
38. DeMartino GN, Slaughter CA: The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 1999;274:22123-22126.
39. Pickart CM: Ubiquitin in chains. Trends Biochem Sci 2000;25:544-548.
40. Alarid ET, Windle JJ, Whyte DB, Mellon PL: Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 1996;122:3319-3329.
41. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A: Regulation of novel protein kinase Cε by phosphorylation. Biochem J 2002;363:537-545.
42. Stempka L, Schnolzer M, Radke S, Rincke G, Marks F, Gschwendt M: Requirements of protein kinase Cδ for catalytic function. Role of glutamic acid 500 and autophosphorylation on serine 643. J Biol Chem 1999;274:8886-8892.
43. Li W, Zhang J, Bottaro DP, Pierce JH: Identification of serine 643 of protein kinase Cδ as an important autophosphorylation site for its enzymatic activity. J Biol Chem 1997;272:24550-24555.
44. Rybin VO, Sabri A, Short J, Braz JC, Molkentin JD, Steinberg SF: Cross-regulation of nPKC isoform function in cardiomyocytes: Role of PKC ε in activation loop phosphorylations and PKC δ in hydrophobic motif phosphorylations. J Biol Chem 2003;278:14555-14564.
45. Mason DR, Arora KK, Mertz LM, Catt KJ: Homologous down-regulation of gonadotropin-releasing hormone receptor sites and messenger ribonucleic acid transcripts in αT3-1 cells. Endocrinology 1994;135:1165-1170.
46. McArdle CA, Davidson JS, Willars GB: The tail of the gonadotrophin- releasing hormone receptor: Desensitization at, and distal to, G protein-coupled receptors. Mol Cell Endocrinol 1999;151:129-136.
47. Lee DH, Goldberg AL: Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 1998;8:397-403.
48. Stempka L, Girod A, Muller HJ, Rincke G, Marks F, Gschwendt M, Bossemeyer D: Phosphorylation of protein kinase Cδ (PKC δ) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKC δ and an alanine 505 mutant in bacteria in a functional form. J Biol Chem 1997;272:6805-6811.
49. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ: Mammalian TOR controls one of two kinase pathways acting upon nPKC δ and nPKC ε. J Biol Chem 1999;274:34758-34764.
50. Grosse R, Roelle S, Herrlich A, Hohn J, Gudermann T: Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin- releasing hormone. J Biol Chem 2000;275:12251-12260.
51. Han XB, Conn PM: The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation. Endocrinology 1999;140:2241-2251.
52. Kraus S, Benard O, Naor Z, Seger R: c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells. J Biol Chem 2003;278:32618-32630.
53. Mulvaney JM, Roberson MS: Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem 2000;275:14182-14189.
54. Yokoi T, Ohmichi M, Tasaka K, Kimura A, Kanda Y, Hayakawa J, Tahara M, Hisamoto K, Kurachi H, Murata Y: Activation of the luteinizing hormone β promoter by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein kinase. J Biol Chem 2000;275:21639-21647.
55. Hansra G, Bornancin F, Whelan R, Hemmings BA, Parker PJ: 12-O-Tetradecanoylphorbol-13-acetate-induced dephosphorylation of protein kinase Cα correlates with the presence of a membrane-associated protein phosphatase 2A heterotrimer. J Biol Chem 1996;271:32785-32788.
56. Gao T, Newton AC: The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J Biol Chem 2002;277:31585-31592.
57. Kordon C, Drouva SV, de la Escalera G, Weiner RI: Role of classic and peptide neuromediators in the neuroendocrine regulation of luteinizing hormone and prolactin; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, chapt 27, pp 1621-1681.
58. Wojcikiewicz RJ, Xu Q, Webster JM, Alzayady K, Gao C: Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1,4,5-trisphosphate receptors in αT3-1 anterior pituitary cells. J Biol Chem 2003;278:940-947.
59. Bokkala S, Joseph SK: Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway. J Biol Chem 1997;272:12454-12461.
60. Busconi L, Guan J, Denker BM: Degradation of heterotrimeric Gα(o) subunits via the proteosome pathway is induced by the hsp90-specific compound geldanamycin. J Biol Chem 2000;275:1565-1569.
61. Chaturvedi K, Bandari P, Chinen N, Howells RD: Proteasome involvement in agonist-induced down-regulation of μ and δ opioid receptors. J Biol Chem 2001;276:12345-12355.
62. Van Kerkhof P, Govers R, Alves dos Santos CM, Strous GJ: Endocytosis and degradation of the growth hormone receptor are proteasome-dependent. J Biol Chem 2000;275:1575-1580.
63. Glickman MH, Ciechanover A: The ubiquitinproteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 2002;82:373-428.
64. Maccario H, Junoy B, Poulin B, Boyer B, Enjalbert A, Drouva SV: PKC ε and PKC δ as GnRH target isoenzymes in αT3-1 and LβT2 gonadotrope cell lines. ENDO 2002, 84th Annual Meeting of the Endocrine Society, San Francisco, P3-252, p 550.